There is extensive and consistent evidence that high intake of fruit and ve
getables is associated with decreased risk of many types of cancers. Thus,
it is widely accepted that diet changes are a powerful tool for cancer prev
ention and for inhibition of cancer progression. The growing interest in th
e role of the tomato carotenoid, lycopene, in cancer prevention and treatme
nt, combined with the hypothesis that a single micronutrient cannot replace
the power of a diet rich in fruit and vegetables, are the basis for this r
eview. The mechanism of lycopene function in cancer cells involves interfer
ence in the mitogenic pathway of IGF-I and slowdown of cell cycle progressi
on. The recent observation that high plasma IGF-I levels is an important ri
sk factor for breast and prostate cancer, similar to the role of cholestero
l in cardiovascular diseases, further places dietary intervention in the fo
cus of anticancer research. Moreover, as suggested by our studies and those
of others, it is possible that derivatives of lycopene and other carotenoi
ds, not only the native molecules themselves, are the active compounds, sin
ce it was found that such derivatives can interact with members of the nucl
ear receptor family. If an active lycopene derivative will be identified by
this approach, it can be used as a parent compound for the development of
a new series of potent anticancer drugs based on natural dietary ingredient
s. (C) 2000 Wiley-Liss, Inc.